Watchlist Price Alert

Infinity Pharmaceuticals ... (INFI)

NASDAQ: INFI · Real-Time Price · USD

0.01

-0.01 (-40.48%)

At close: Sep 29, 2023, 7:59 PM

Infinity Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	2.57M	2.67M	2.59M	2.5M	2.22M	2.04M	1.86M	1.84M	1.91M	1.76M	1.72M	1.59M	1.44M	1.34M	3.05M	2.89M	24.55M	24.29M	22.15M	22M	6M	6M	6M	6M	n/a	9.47M	18.72M	27.8M	118.55M	113.96M
Cost of Revenue	1.55M	1.61M	1.56M	1.51M	1.34M	1.23M	1.12M	1.11M	1.15M	1.06M	1.04M	959K	867K	805K	7.31M	7.12M	6.92M	6.76M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	1.02M	1.06M	1.03M	993K	880K	812K	738K	732K	759K	698K	683K	633K	572K	531K	-4.26M	-4.24M	17.63M	17.53M	22.15M	22M	6M	6M	6M	6M	n/a	9.47M	18.72M	27.8M	118.55M	113.96M
Operating Income	-42.05M	-43.94M	-44.84M	-46.81M	-46.67M	-45.91M	-45.08M	-43.82M	-41.91M	-39.58M	-38.5M	-39.82M	-41.55M	-42.38M	-45.66M	-42.56M	-18.8M	-16.19M	-11.93M	-11.49M	-32.52M	-35.49M	-36.45M	-51.66M	-63.75M	-599K	-30.89M	-46.82M	16.38M	-75.26M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-40.95M	-42.98M	-44.37M	-46.79M	-46.79M	-46.07M	-45.26M	-44.21M	-43.03M	-41.23M	-40.49M	-41.27M	-43.16M	-44.2M	-47.11M	-43.95M	-19.15M	-15.6M	-11.25M	-11.05M	-31.54M	-41.53M	-42.55M	-57.46M	-69.86M	88K	-30.1M	-46.51M	16.02M	-75.4M
Net Income	-39.91M	-41.91M	-43.71M	-46.59M	-46.75M	-46.07M	-45.26M	-44.21M	-43.03M	-41.23M	-40.49M	-41.27M	-43.16M	-44.2M	-47.06M	-43.9M	-19.1M	-15.55M	-11.25M	-10.33M	-30.82M	-40.81M	-41.83M	-57.46M	-69.86M	88K	-30.1M	-46.36M	15.68M	-75.74M
Selling & General & Admin	15.99M	15.73M	13.46M	13.94M	14.28M	14.28M	14.17M	14.14M	13.22M	12.66M	12.42M	12.67M	13.38M	14.21M	14.29M	14.62M	14.42M	14.04M	14.25M	14.9M	15.96M	18.78M	21.61M	25.72M	28.33M	37.82M	42.22M	43M	45.63M	39.35M
Research & Development	27.08M	29.27M	32.41M	33.86M	33.27M	32.44M	31.65M	30.41M	29.45M	27.62M	26.76M	27.78M	28.75M	28.7M	27.12M	23.64M	21.94M	19.61M	19.76M	18.59M	22.55M	22.7M	20.83M	31.94M	35.42M	84.46M	119.61M	143.84M	168.75M	149.87M
Other Expenses	2.79M	2.85M	2.41M	843K	414K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	202K	202K	202K	202K	n/a	-6.88M	-6.88M	-6.88M	-6.88M	n/a	n/a	n/a	n/a	n/a
Operating Expenses	43.07M	45.01M	45.87M	47.8M	47.55M	46.72M	45.82M	44.55M	42.67M	40.28M	39.18M	40.45M	42.13M	42.91M	41.41M	38.26M	36.36M	33.65M	34.01M	33.49M	38.52M	41.49M	42.45M	57.66M	63.75M	122.28M	161.83M	186.84M	214.39M	189.22M
Interest Expense	180K	180K	180K	180K	180K	180K	180K	778K	1.36M	1.92M	2.44M	1.84M	2.35M	2.83M	2.56M	2.53M	1.39M	304K	93K	214K	501K	801K	1.01M	1.19M	1.21M	1.22M	1.23M	1.23M	1.24M	1.03M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	44.62M	46.62M	47.44M	49.31M	48.89M	47.95M	46.94M	45.66M	43.82M	41.34M	40.22M	41.41M	42.99M	43.72M	48.71M	45.45M	43.35M	40.48M	34.07M	33.49M	38.52M	41.49M	42.45M	57.66M	63.75M	122.28M	161.83M	186.84M	214.39M	189.22M
Income Tax Expense	-995K	-1.07M	-610K	-106K	103K	180K	180K	778K	1.36M	1.92M	2.44M	1.7M	2.21M	2.69M	2.07M	2.17M	1.03M	-226K	-79K	-799K	-512K	-6.92M	-6.71M	-6.54M	-6.52M	366K	373K	776K	951K	743K
Shares Outstanding (Basic)	89.89M	89.41M	89.25M	89.39M	89.16M	89.16M	89.09M	88.77M	88.66M	75.73M	64.12M	60.51M	57.44M	57.34M	57.04M	57.03M	56.94M	56.92M	56.89M	56.85M	55.97M	51.88M	50.72M	50.64M	50.46M	50.42M	50.1M	49.58M	49.44M	49.34M
Shares Outstanding (Diluted)	89.89M	89.41M	89.25M	89.39M	89.16M	89.16M	89.09M	88.77M	88.66M	75.73M	64.12M	60.51M	57.44M	57.34M	57.04M	57.03M	56.94M	56.92M	56.89M	57.64M	55.97M	51.88M	50.72M	50.64M	50.46M	50.42M	50.1M	49.58M	49.44M	49.34M
EPS (Basic)	-0.45	-0.47	-0.49	-0.52	-0.52	-0.52	-0.53	-0.57	-0.61	-0.64	-0.68	-0.71	-0.75	-0.77	-0.82	-0.76	-0.33	-0.27	-0.21	-0.21	-0.58	-0.8	-0.83	-1.15	-1.4	-0.01	-0.62	-0.96	0.28	-1.55
EPS (Diluted)	-0.45	-0.47	-0.49	-0.52	-0.52	-0.52	-0.53	-0.57	-0.61	-0.64	-0.68	-0.71	-0.75	-0.77	-0.82	-0.76	-0.33	-0.27	-0.21	-0.21	-0.58	-0.8	-0.83	-1.15	-1.4	-0.01	-0.62	-0.96	0.27	-1.56
EBITDA	-41.72M	-43.61M	-44.49M	-46.33M	-46.19M	-45.43M	-44.6M	-43.82M	-42.04M	-39.7M	-38.62M	-39.58M	-41.25M	-42.2M	-45.6M	-42.47M	-18.73M	-16.23M	-11.91M	-11.5M	-32.31M	-41.35M	-41.68M	-56.9M	-68.07M	-110.25M	-140.54M	-156.47M	-93.87M	-73.36M
EBIT	-40.77M	-42.8M	-44.19M	-46.61M	-46.61M	-45.89M	-45.08M	-43.43M	-41.67M	-39.32M	-38.05M	-39.43M	-40.81M	-41.37M	-44.55M	-33.2M	-22.92M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	428K	442K	458K	472K	482K	482K	480K	479K	480K	482K	483K	501K	443K	329K	219K	112K	93K	138K	191K	231K	447K	1.09M	1.72M	2.5M	3.42M	3.42M	3.42M	3.3M	2.71M	2.63M